Author/Authors :
İçme, Ferhat Ankara Atatürk Eğitim ve Araştırma Hastanesi - Acil Servis, Turkey , Temrel, Tuğba Ankara Atatürk Eğitim ve Araştırma Hastanesi - Acil Servis, Turkey , Kavaklı, Havva Şahin Ankara Atatürk Eğitim ve Araştırma Hastanesi - Acil Servis, Turkey , Yüzbaşıoğlu, Yücel Ankara Atatürk Eğitim ve Araştırma Hastanesi - Acil Servis, Turkey , Çelik, Gülhan Kurtoğlu Ankara Atatürk Eğitim ve Araştırma Hastanesi - Acil Servis, Turkey , Öztürk, Zeynep Saral Ankara Atatürk Eğitim ve Araştırma Hastanesi - Acil Servis, Turkey
Abstract :
Fibrates are derivative of fibric acid and broad spectrum drugs which are commonly used in the treatment of dyslipidemia and hypertriglyceridemia. Side effects are often related with striated muscles, kidney and liver. Rhabdomyolysis developing with striated muscle destruction is potentially the most lethal of these side effects. Although several cases of rhabdomyolysis have been reported due to the combination of statin and fenofibrate, fenofibrate alone rarely causes rhabdomyolysis. The purposes of this paper are to present a patient whom we diagnosed with acute renal injury due to use of fenofibrate in order to emphasize the importance of questioning drugs which have been used, and to review management of rhabdomyolysis due to fenofibrate use.
